-
Cochin Shipyard
2,547.25 2,977.10(%) -
Azad Engineering
1,561.00 1,128.40(%) -
Garden Reach Sh.
3,199.05 1,180.10(%) -
HDFC Bank
1,996.30 1,996.30(%) -
Reliance Industr
1,451.35 1,608.95(%) -
Reliance Power
63.13 63.39(%) -
Natl. Aluminium
190.90 263.10(%) -
HFCL
92.19 171.00(%) -
Ramkrishna Forg.
674.40 1,064.00(%) -
Suzlon Energy
66.10 46.00(%) -
IDFC First Bank
72.25 84.50(%) -
Sika Interplant
1,265.00 399.96(%) -
Multi Comm. Exc.
7,529.95 7,529.95(%) -
St Bk of India
816.45 898.80(%) -
Mazagon Dock
3,380.30 1,417.20(%) -
Hindustan Zinc
510.75 717.10(%) -
ICICI Bank
1,461.95 1,471.10(%) -
REC Ltd
417.30 653.90(%) -
Eternal Ltd
264.10 304.50(%) -
Bharat Electron
389.05 240.15(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Solara Active Pharma Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 70281.0
- ISIN : INE624Z01016
-
Today’s Low
472.05 -
Today’s High
476.45

-
Open
476.00 -
Perv Close
472.85 -
52W Low
390.95 -
52W High
882.80
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
2,105.01
-
Div & Yield %
0.00
-
Book Value(₹)
302.88
-
Debt-Equity Ratio
0.41
-
AGM Date
06-Jun-2025
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.83
-
Mar.Cap (₹Cr.)
2,105.01
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
36.05
-
BV (₹)
302.90
-
Sales( ₹ in Cr.)
1,283.76
-
NP (in Cr.)
-1.08
-
NP Var(%)
100.0
-
Div%
0.0
-
CPS (₹)
27.20
-
EPS (₹)
-0.30
-
Traded Value (₹ in Lakhs)
2,106.69
-
52 Week High
882.80
-
52 Week Low
390.95
-
Price BSE
475.0
-
Price NSE
475.00
-
Market Capital( in Cr.)
2,106.69
-
P/C Ratio
17.40
-
P/E Ratio
-1,585.70
-
Price Vs.BV
-0.30
-
15-May-2025( 05:30)
Results - Announcements - Solar... - Net Loss of Solara Active Phar...
-
12-May-2025( 08:36)
Hot Pursuit - Solar... - The Agency with their designat...
-
07-May-2025( 05:24)
Corporate News - Solar... - Solara Active Pharma Sciences...
-
27-Mar-2025( 10:23)
Corporate News - Solar... - Solara Active Pharma Sciences...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 | 1,321.75 | 1,386.68 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 | 1,321.75 | 1,386.68 |
Other Income | 5.37 | 22.14 | 18.76 | 28.41 | 27.51 | 12.03 |
Stock Adjustments | -39.27 | -7.05 | 258.75 | 2.15 | 54.16 | 33.79 |
Total Income | 1,255.02 | 1,458.90 | 1,545.85 | 1,647.44 | 1,403.42 | 1,432.50 |
EXPENDITURE : | ||||||
Raw Materials | 765.75 | 781.78 | 912.64 | 726.56 | 653.03 | 738.62 |
Power and Fuel Cost | 122.56 | 107.95 | 93.70 | 85.42 | 77.68 | 79.35 |
Employee Cost | 243.92 | 228.05 | 234.20 | 227.63 | 202.24 | 183.98 |
Other Manufacturing Expenses | 109.31 | 90.76 | 97.87 | 91.19 | 89.50 | 91.58 |
Selling and Administration Expenses | 70.40 | 67.50 | 76.39 | 76.07 | 74.19 | 64.70 |
Miscellaneous Expenses | 222.41 | 26.68 | 35.43 | 26.83 | 22.74 | 48.38 |
Employee Benefit Expenses | 243.92 | 228.05 | 234.20 | 227.63 | 202.24 | 183.98 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,534.35 | 1,302.72 | 1,450.23 | 1,233.70 | 1,119.38 | 1,206.61 |
Operating Profit | -279.33 | 156.18 | 95.62 | 413.74 | 284.04 | 225.89 |
Interest | 105.97 | 90.06 | 75.27 | 84.47 | 77.88 | 82.42 |
Gross Profit | -385.30 | 66.12 | 20.35 | 329.27 | 206.16 | 143.47 |
Depreciation | 103.03 | 110.90 | 112.01 | 108.31 | 93.67 | 82.79 |
Profit Before Tax | -488.33 | -44.78 | -91.66 | 220.96 | 112.49 | 60.68 |
Current Tax | 0.00 | -0.11 | 0.00 | 38.64 | 20.69 | 15.96 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 78.54 | -22.46 | -33.10 | -38.64 | -20.69 | -13.95 |
Reported Net Profit | -566.87 | -22.21 | -58.56 | 220.96 | 112.49 | 58.67 |
Extraordinary Items | -158.84 | -0.45 | -4.26 | 1.65 | -0.26 | 0.32 |
Adjusted Net Profit | -408.03 | -21.76 | -54.30 | 219.31 | 112.75 | 58.35 |
Adjustment below Net Profit | 0.56 | -1.76 | 2.01 | -2.53 | -3.85 | -10.70 |
P & L Balance brought forward | 250.04 | 274.01 | 341.34 | 142.65 | 49.67 | 1.70 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 10.78 | 19.74 | 15.66 | 0.00 |
P & L Balance carried down | -316.27 | 250.04 | 274.01 | 341.34 | 142.65 | 49.67 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 30.00 | 0.00 | 70.00 | 20.00 | 50.00 |
Dividend Per Share(Rs) | 0.00 | 3.00 | 0.00 | 7.00 | 2.00 | 5.00 |
Earnings Per Share-Unit Curr | -157.46 | -6.17 | -16.27 | 61.50 | 41.90 | 22.77 |
Earnings Per Share(Adj)-Unit Curr | -145.12 | -5.69 | -15.00 | 56.68 | 38.62 | 20.99 |
Book Value | 260.39 | 417.54 | 424.18 | 443.30 | 370.50 | 333.12 |
Book Value(Adj)-Unit Curr | 239.98 | 384.83 | 390.94 | 408.56 | 341.46 | 307.01 |